Abstract
Neural stem cells (NSCs) led to the development of a novel strategy for delivering therapeutic genes to brain tumors. Human NSCs expressing rabbit carboxyl esterase (F3.CE), which activates CPT-11, significantly inhibit the growth of A549 human non-small cell lung adenocarcinoma cells in the presence of CPT-11 in vitro and in vivo. F3.CE cells migrated selectively into the brain metastases located in the opposite hemisphere. The treatment also significantly decreased tumor volume in immune-deficient mice bearing lung cancer when F3.CE cells were transplanted into the contralateral hemisphere. The survival of tumor-bearing animals was significantly prolonged by the treatment with F3.CE and CPT-11. This strategy could be considered as an effective treatment regimen for lung cancer brain metastases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gavrilovic IT, Posner JB . Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005; 75: 5–14.
Schuette W . Treatment of brain metastases from lung cancer: chemotherapy. Lung Cancer 2004; 45 (Suppl 2): S253–S257.
Shaffrey ME, Mut M, Asher AL, Burri SH, Chahlavi A, Chang SM et al. Brain metastases. Curr Probl Surg 2004; 41: 665–741.
Aboody KS, Najbauer J, Schmidt NO, Yang W, Wu JK, Zhuge Y et al. Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. NeuroOncol 2006; 8: 119–126.
Schmidt NO, Przyleck W, Yang W, Ziu M, Teng Y, Kim SU et al. Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 2005; 7: 623–629.
Kim SU . Neural stem cell-based gene therapy for brain tumors. Stem Cell Rev 2010; 7: 130–140.
Kim SK, Kim SU, Park IH, Bang JH, Aboody KS, Wang KC et al. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res 2006; 15: 5550–5556.
Shimato S, Natsume A, Takeuchi H, Wakabayashi T, Fujii M, Ito M et al. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma. Gene Ther 2007; 15: 1132–1142.
Kendall S, Najbauer J, Johnston HF, Metz M, Li S, Bowers M et al. Neural stem cell targeting of glioma is dependent on PI3K signaling. Stem Cells 2008; 26: 11575–11586.
Joo K, Park IH, Shin JY, Jin J, Kang BG, Kim SY et al. Human neural stem cells target and deliver therapeutic genes to breast cancer brain metastasis. Mol Ther 2009; 17: 570–575.
Kim JH, Lee JE, Kim SU, Cho KG . Stereological analysis on migration of human neural stem cells in the brain of rats bearing glioma. Neurosurgery 2010; 66: 333–342.
Aboody KS, Bush RA, Garcia E, Metz MZ, Najbauer J, Justus KA et al. Development of a tumor-selective approach to treat metastatic cancer. PLoS One 2006; 1: e23.
Danks MK, Yoon KJ, Bush RA, Remack JS, Weird M, Tsurkan L et al. Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma. Cancer Res 2007; 67: 22–25.
Yi BR, Kim SU, Kim YB, Lee HJ, Cho MH, Choi KC . Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties. Oncol Rep 2012; 27: 1823–1828.
Lim SH, Choi SA, Lee JY, Wang KC, Phi JH, Lee DH et al. Therapeutic targeting of subdural medulloblastomas using human neural stem cells expressing carboxylesterase. Cancer Gene Ther 2011; 18: 817–824.
Seol HJ, Jin J, Seong DH, Joo KM, Kang W, Yang H et al. Genetically engineered human neural stem cells with rabbit carboxyl esterase can target b rain metastasis from breast cancer. Cancer Lett 2011; 311: 152–159.
Zhao D, Najbauer J, Annala AJ, Garcia E, Metz MZ, Gutova M et al. Human neural stem cell tropism to metastatic breast cancer. Stem Cells 2012; 30: 314–325.
Wang C, Natsume A, Lee HJ, Motomura M, Nishimira Y, Ohno Y et al. Neural stem cell-based dual suicide gene delivery for metastatic brain tumors. Cancer Gene Ther 2012; 19: 796–801.
Kim SU . Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 2004; 24: 159–171.
Lee HJ, Kim KS, Kim EJ, Lee KH, Choi HB, Park IH et al. Brain transplantation of human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model. Stem Cells 2007; 25: 211–224.
Kim SU, Nagai A, Nakagawa E, Choi HB, Bang JH, Lee HJ et al. Production and characterization of immortal human neural stem cell line with multipotent differentiation property. Methods Mol Biol 2008; 438: 103–121.
Potter PM, Pawlik CA, Morton CL, Naeve CW, Danks MK . Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT-11). Cancer Res 1998; 58: 2646–2651.
Aboody KS, Najbauer J, Danks MK . Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther 2008; 15: 739–752.
Prados MD, Lamborn K, Yung WK, Jaeckle K, Robins HI, Mehta M et al. A phase II trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Neuro Oncol 2006; 8: 189–193.
Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Friedman AH et al. Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy. J Neurooncol 2009; 95: 393–400.
de Groot JF, Yung WK . Bevacizumab and irinotecan in the treatment of recurrent malignant gliomas. Cancer J 2008; 14: 279–285.
Poulsen HS, Grunnet K, Sorensen M, Olsen P, Hasselbalch B, Nelausen K et al. Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours. Acta Oncol 2009; 48: 52–58.
Acknowledgements
This study was supported by grants from Korea Healthcare Technology R&D Project (A092255) and R&D Program for Cancer Control, Korean Ministry of Health & Welfare (SUK), Asan Life Science Institute (2008-436), Seoul, Korea (SHH), and Canadian Myelin Research Initiative (SUK).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Hong, S., Lee, H., An, J. et al. Human neural stem cells expressing carboxyl esterase target and inhibit tumor growth of lung cancer brain metastases. Cancer Gene Ther 20, 678–682 (2013). https://doi.org/10.1038/cgt.2013.69
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cgt.2013.69
Keywords
This article is cited by
-
Next-generation Tumor-homing Induced Neural Stem Cells as an Adjuvant to Radiation for the Treatment of Metastatic Lung Cancer
Stem Cell Reviews and Reports (2022)
-
Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients
Cancer Gene Therapy (2021)
-
Tumor-homing Stem Cell Therapy for Brain Cancer
Current Surgery Reports (2017)
-
Stem cell-based therapies for cancer treatment: separating hope from hype
Nature Reviews Cancer (2014)